UPSC has extended the NDA & CDS I 2025 registration deadline to 6 PM on 1 January 2025 due to technical issues. Candidates ...

The UPSC will end the registration window for NDA 1 on December 31. Candidates can apply for the NDA 1 registration at the ...

The article below provides detailed information about the NDA and CDS online application process, which includes application fees and other important information. Candidates who want to join the ...

The Union Public Service Commission (UPSC) has extended the registration deadline for the NDA & CDS I 2025 exams until ...

The FDA has granted priority review to an NDA for taletrectinib in the treatment of advanced ROS1-positive non–small cell ...

Sentynl took over the therapy’s development and commercialisation from Fortress Biotech's subsidiary Cyprium Therapeutics.

An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade ...

Priority review granted for CUTX-101 with PDUFA target action date set for June 30, 2025 Cyprium is eligible to receive ...

UPSC NDA & NA I Exam 2025 registration closes today, December 31. Eligible candidates can apply online and make corrections ...

Fortress Biotech (FBIO) and its majority-owned subsidiary, Cyprium Therapeutics announced the acceptance for review of the New Drug Application ...